Evercore ISI Group Maintains Outperform on American Homes 4 Rent, Lowers Price Target to $37
Evercore ISI Group analyst Steve Sakwa maintains American Homes 4 Rent (NYSE:AMH) with a Outperform and lowers the price target from $38 to $37.
Stocks · News reference
This Macerich Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Analysts upgraded MAC, INVH, CIEN, AMH and CADL, raising ratings and several price targets.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Mizuho Upgrades American Homes 4 Rent to Outperform, Raises Price Target to $36
Mizuho analyst Haendel St. Juste upgrades American Homes 4 Rent (NYSE:AMH) from Neutral to Outperform and raises the price target from $35 to $36.
Scotiabank Maintains Sector Perform on American Homes 4 Rent, Lowers Price Target to $31
Scotiabank analyst Nicholas Yulico maintains American Homes 4 Rent (NYSE:AMH) with a Sector Perform and lowers the price target from $33 to $31.
Candel Therapeutics shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $12 to $18.
B of A Securities Upgrades Candel Therapeutics to Buy, Raises Price Target to $18
B of A Securities analyst Alec Stranahan upgrades Candel Therapeutics (NASDAQ:CADL) from Neutral to Buy and raises the price target from $12 to $18.
8-K filing — Candel Therapeutics, Inc. (CADL)
Filed: 2026-09-10 AccNo: 0001193125-26-387310 Size: 231 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits